Earnings History Data for Virios Therapeutics, Inc. (VIRI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Virios Therapeutics, Inc.
Virios Therapeutics Inc. is a biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics Inc. is based in Alpharetta, Georgia.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-08-2024 | PM | VIRI | Virios Therapeutics, Inc. | 3.74 | -0.05 | -0.07 | -0.08 | 0.1770 | -0.01 (-5.50%) |
0.18 | -0.01 (-4.43%) |
0.16 - 1.82 | 796,779 | 560,000 | 8,316 | |||
|
|
||||||||||||||||||
| 09-05-2024 | PM | VIRI | Virios Therapeutics, Inc. | 7.95 | -0.07 | -0.08 | -0.08 | Virios Therapeutics GAAP EPS of -$0.07 misses by $0.03 [5/9/2024 8:16 AM] |
0.3727 | -0.06 (-13.12%) |
0.42 | -0.01 (-3.03%) |
0.28 - 2.42 | 367,468 | 70,000 | 29,172 | ||
| 29-02-2024 | PM | VIRI | Virios Therapeutics | 7.00 | -0.06 | -0.09 | 0.00 | 0.3825 | 0.0 (0.68%) |
0.0 | 0.0 (0.00%) |
0.28 - 2.42 | 113,234 | 140,000 | 0 | |||
|
|
||||||||||||||||||
| 13-11-2023 | PM | VIRI | Virios Therapeutics, Inc. | 14.44 | -0.06 | -0.10 | -0.28 | Virios Therapeutics GAAP EPS of -$0.06 beats by $0.04 [11/13/2023 7:20 AM] |
0.6933 | -0.08 (-10.54%) |
0.83 | 0.05 (6.54%) |
0.22 - 2.42 | 269,495 | 1,690,000 | 23,224 | ||
| 10-08-2023 | PM | VIRI | Virios Therapeutics, Inc. | 30.98 | -0.08 | -0.07 | -0.44 | Virios Therapeutics GAAP EPS of -$0.08 beats by $0.01 [8/10/2023 7:08 AM] |
1.06 | -0.51 (-32.58%) |
1.47 | -0.10 (-6.37%) |
0.22 - 9.11 | 3,865,699 | 440,000 | 247,206 | ||
| 11-05-2023 | PM | 7:05 AM ET (May 11) |
VIRI | Virios Therapeutics, Inc. | 18.06 | -0.08 | 0.00 | -0.48 | Virios Therapeutics GAAP EPS of -$0.08 beats by $0.12 [5/11/2023 10:03 AM] |
1.07 | -0.08 (-6.96%) |
1.04 | -0.11 (-9.57%) |
0.22 - 9.11 | 1,252,707 | 1,230,000 | 457,649 | |
| 14-03-2023 | PM | 7:05 AM ET (Mar 14) |
VIRI | Virios Therapeutics, Inc. | 5.88 | -0.11 | -0.16 | -0.54 | Virios Therapeutics GAAP EPS of -$0.11 beats by $0.04 [3/14/2023 7:11 AM] |
0.33 | 0.01 (3.19%) |
0.33 | 0.01 (3.16%) |
0.22 - 9.11 | 376,519 | 500,000 | 38,949 | |
| 14-11-2022 | PM | 7:05 AM ET (Nov 14) |
VIRI | Virios Therapeutics, Inc. | 6.08 | -0.28 | -0.49 | -0.49 | Virios Therapeutics GAAP EPS of -$0.28 beats by $0.21 [11/14/2022 7:27 AM] |
0.3390 | -0.02 (-5.83%) |
0.36 | 0.0 (0.00%) |
0.26 - 9.11 | 192,020 | 290,000 | 13,221 | |
| 11-08-2022 | PM | 7:05 AM ET (Aug 11) |
VIRI | Virios Therapeutics, Inc. | 56.56 | -0.44 | -0.50 | -0.51 | Virios Therapeutics GAAP EPS of -$0.44 beats by $0.07 [8/11/2022 7:23 AM] |
7.68 | 0.59 (8.31%) |
7.19 | 0.10 (1.40%) |
3.30 - 7.95 | 112,143 | 20,000 | 235 | |
| 12-05-2022 | PM | 7:05 AM ET (May 12) |
VIRI | Virios Therapeutics, Inc. | 29.49 | -0.48 | -0.54 | -0.37 | Virios Therapeutics GAAP EPS of -$0.48 [5/12/2022 7:10 AM] |
3.49 | 0.18 (5.44%) |
3.36 | 0.05 (1.51%) |
3.30 - 7.45 | 23,725 | 20,000 | 4,225 | |
| 17-03-2022 | PM | 7:05 AM ET (Mar 17) |
VIRI | Virios Therapeutics, Inc. | 41.74 | -0.54 | -0.68 | -1.25 | Virios Therapeutics GAAP EPS of -$0.54 beats by $0.29 [3/17/2022 7:14 AM] |
5.65 | 0.53 (10.27%) |
5.60 | 0.48 (9.38%) |
4.00 - 7.45 | 13,766 | 22,965 | 0 | |
| 11-11-2021 | PM | 7:05 AM ET (Nov 11) |
VIRI | Virios Therapeutics, Inc. | 47.23 | -0.49 | -0.70 | 0.00 | Virios Therapeutics EPS beats by $0.21 [11/11/2021 7:12 AM] |
5.50 | -0.05 (-0.90%) |
0.0 | 0.0 (0.00%) |
4.00 - 16.71 | 10,667 | 60,000 | 0 | |
| 12-08-2021 | PM | 7:05 AM ET (Aug 12) |
VIRI | Virios Therapeutics, Inc. | 45.73 | -0.51 | -0.57 | 0.00 | Virios Therapeutics EPS beats by $0.06 [8/12/2021 7:20 AM] |
5.48 | 0.14 (2.62%) |
5.40 | 0.06 (1.12%) |
4.60 - 16.71 | 7,562 | 20,000 | 100 | |
| 13-05-2021 | PM | Before the open (May 13) |
VIRI | Virios Therapeutics, Inc. | 40.74 | -0.37 | 0.00 | 0.00 | Virios Therapeutics reports Q1 results [5/13/2021 7:08 AM] |
4.71 | -0.10 (-2.08%) |
0.0 | 0.0 (0.00%) |
4.60 - 16.71 | 28,908 | 30,000 | 0 | |
| 18-03-2021 | PM | Before the open (Mar 18) |
VIRI | Virios Therapeutics, Inc. | 52.18 | -1.25 | 0.00 | 0.00 | Virios Therapeutics reports Q4 results [3/18/2021 8:09 AM] |
5.70 | -0.46 (-7.45%) |
6.06 | -0.10 (-1.62%) |
4.60 - 16.71 | 59,343 | 130,000 | 2,544 | |